The future of systemic therapy for cutaneous squamous cell carcinoma (CSCC) is rapidly evolving, with research focused on ...
New immunologic and biomarker data supports the potential of ITK inhibition with soquelitinib to increase persistent Treg ...
In this systematic review and cohort study, researchers aimed to determine whether receipt of guideline-concordant systemic therapy is associated with OS in iCCA patients.
Systemic therapy is often given late due to optimism bias, treatment momentum, and difficulty in end-of-life conversations, leading to increased hospitalizations and ICU admissions. MD Anderson Cancer ...
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy This trial randomly ...
Andy Blauvelt, MD, MBA, president of Oregon Medical Research Center, discusses the use of systemic therapies vs biologics and why adherence is so important when treating patients with atopic ...
CAR T therapy spreads beyond academic centers, but insurance, cost and policy gaps keep most eligible lymphoma patients from ...
Dr. Michael Atkins and Dr. Vernon Sondak highlight the latest updates to the systemic therapy for melanoma recommendations in this newest guideline. The discussion covers neoadjuvant and adjuvant ...
An analysis of more than 250,000 older adults diagnosed with metastatic non-small cell lung cancer showed only about half ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results